Mercer Global Advisors Inc Astrazeneca PLC Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Mercer Global Advisors Inc holds 135,497 shares of AZN stock, worth $11.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
135,497
Previous 164,507
17.63%
Holding current value
$11.2 Million
Previous $12.1 Million
21.69%
% of portfolio
0.02%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...